STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Companyâs principal products are ICLs used in refractive surgery, including its EVO family of lenses.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSTAA
āļāļ·āđāļāļāļĢāļīāļĐāļąāļSTAAR Surgical Co
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 24, 1992
āļāļĩāļāļĩāđāļFarrell (Stephen C)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ1157
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļFeb 24
āļāļĩāđāļāļĒāļđāđ1911 Walker Ave
āđāļĄāļ·āļāļMONROVIA
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ91016
āđāļāļĢāļĻāļąāļāļāđ16263037902
āđāļ§āđāļāđāļāļāđhttps://www.staar.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļSTAA
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 24, 1992
āļāļĩāļāļĩāđāļFarrell (Stephen C)
Mr. Warren Foust
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
Ms. Deborah J. Andrews
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
Mr. Neal C. Bradsher
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Richard T. LeBuhn
Independent Director
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Warren Foust
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
Ms. Deborah J. Andrews
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary